Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders.

Recent News

Get the Cybin
Investor’s Kit now.

Compounds

Market Cap

NASDAQ: CYBN

Focus